{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:07:16Z","timestamp":1791090436721,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korean Fund for Regenerative Medicine (KFRM) grant funded by the Ministry of Science and ICT","award":["KFRM 21A0502L1-12"],"award-info":[{"award-number":["KFRM 21A0502L1-12"]}]},{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute","award":["HI21C1829"],"award-info":[{"award-number":["HI21C1829"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88362-0","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T07:24:11Z","timestamp":1739172251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oral trehalose improves histological and behavior symptoms of mucopolysaccharidosis type II in iduronate 2-sulfatase deficient mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Hyesook","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hwa","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roo Gam","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Jeong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Rin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Kun","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"88362_CR1","unstructured":"Neufeld, E. F. & Muenzer, J. In The Online Metabolic and Molecular Bases of Inherited Disease (eds D. L. Valle et al.) (McGraw-Hill Education, 2019)."},{"key":"88362_CR2","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1073\/pnas.70.7.2134","volume":"70","author":"G Bach","year":"1973","unstructured":"Bach, G., Eisenberg, F. Jr., Cantz, M. & Neufeld, E. F. The defect in the Hunter syndrome: Deficiency of sulfoiduronate sulfatase. Proc. Natl. Acad. Sci. 70, 2134\u20132138. https:\/\/doi.org\/10.1073\/pnas.70.7.2134 (1973).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"88362_CR3","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1155\/2012\/471325","volume":"471325\u2013471340","author":"MF Coutinho","year":"2012","unstructured":"Coutinho, M. F., Lacerda, L. & Alves, S. Glycosaminoglycan storage disorders: A review. Biochem. Res. Int. 471325\u2013471340, 2012. https:\/\/doi.org\/10.1155\/2012\/471325 (2012).","journal-title":"Biochem. Res. Int."},{"key":"88362_CR4","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.1542\/peds.2007-1350","volume":"121","author":"R Martin","year":"2008","unstructured":"Martin, R. et al. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 121, e377\u2013e386. https:\/\/doi.org\/10.1542\/peds.2007-1350 (2008).","journal-title":"Pediatrics"},{"key":"88362_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/ijms24010477","volume":"24","author":"AF Leal","year":"2022","unstructured":"Leal, A. F. et al. Mucopolysaccharidoses: Cellular consequences of glycosaminoglycans accumulation and potential targets. Int. J. Mol. Sci. 24, 477\u2013497. https:\/\/doi.org\/10.3390\/ijms24010477 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"88362_CR6","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3390\/ijms21072515","volume":"21","author":"S Fecarotta","year":"2020","unstructured":"Fecarotta, S., Tarallo, A., Damiano, C., Minopoli, N. & Parenti, G. Pathogenesis of Mucopolysaccharidoses, an update. Int. J. Mol. Sci. 21, 2515\u20132528. https:\/\/doi.org\/10.3390\/ijms21072515 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"88362_CR7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/ijms23041999","volume":"23","author":"O Mandolfo","year":"2022","unstructured":"Mandolfo, O., Parker, H. & Bigger, B. Innate immunity in mucopolysaccharide diseases. Int. J. Mol. Sci. 23, 1999\u20132018. https:\/\/doi.org\/10.3390\/ijms23041999 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"88362_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/jnc.14632","volume":"148","author":"H Parker","year":"2019","unstructured":"Parker, H. & Bigger, B. W. The role of innate immunity in mucopolysaccharide diseases. J. Neurochem. 148, 639\u2013651. https:\/\/doi.org\/10.1111\/jnc.14632 (2019).","journal-title":"J. Neurochem."},{"key":"88362_CR9","doi-asserted-by":"publisher","first-page":"863667","DOI":"10.3389\/fphar.2022.863667","volume":"13","author":"AM Wiesinger","year":"2022","unstructured":"Wiesinger, A. M. et al. The inflammation in the cytopathology of patients with mucopolysaccharidoses-immunomodulatory drugs as an approach to therapy. Front. Pharmacol. 13, 863667\u2013863686. https:\/\/doi.org\/10.3389\/fphar.2022.863667 (2022).","journal-title":"Front. Pharmacol."},{"key":"88362_CR10","first-page":"21","volume":"36","author":"P Li","year":"1999","unstructured":"Li, P., Bellows, A. B. & Thompson, J. N. Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome). J. Med. Genet. 36, 21\u201327 (1999).","journal-title":"J. Med. Genet."},{"key":"88362_CR11","doi-asserted-by":"publisher","first-page":"107539","DOI":"10.1016\/j.ymgme.2023.107539","volume":"138","author":"MC Smith","year":"2023","unstructured":"Smith, M. C. et al. Generation and characterization of an immunodeficient mouse model of mucopolysaccharidosis type II. Mol. Genet. Metab. 138, 107539. https:\/\/doi.org\/10.1016\/j.ymgme.2023.107539 (2023).","journal-title":"Mol. Genet. Metab."},{"key":"88362_CR12","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/ijms21030956","volume":"21","author":"J Lukas","year":"2020","unstructured":"Lukas, J. et al. Assessment of gene variant amenability for pharmacological chaperone therapy with 1-deoxygalactonojirimycin in Fabry disease. Int. J. Mol. Sci. 21, 956\u2013998. https:\/\/doi.org\/10.3390\/ijms21030956 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"88362_CR13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/gim.2017.30","volume":"19","author":"LA Bradley","year":"2017","unstructured":"Bradley, L. A., Haddow, H. R. M. & Palomaki, G. E. Treatment of mucopolysaccharidosis type II (Hunter syndrome): Results from a systematic evidence review. Genet. Med. 19, 1187\u20131201. https:\/\/doi.org\/10.1038\/gim.2017.30 (2017).","journal-title":"Genet. Med."},{"key":"88362_CR14","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1080\/15548627.2018.1474313","volume":"14","author":"P Lotfi","year":"2018","unstructured":"Lotfi, P. et al. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency. Autophagy 14, 1419\u20131434. https:\/\/doi.org\/10.1080\/15548627.2018.1474313 (2018).","journal-title":"Autophagy"},{"key":"88362_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2133.2004.05944.x","volume":"151","author":"K Ito","year":"2004","unstructured":"Ito, K. et al. The effect of haematopoietic stem cell transplant on papules with \u2018pebbly\u2019 appearance in Hunter\u2019s syndrome. Br. J. Dermatol. 151, 207\u2013211. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.05944.x (2004).","journal-title":"Br. J. Dermatol."},{"key":"88362_CR16","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.pedneo.2022.10.001","volume":"64","author":"M Penon-Portmann","year":"2023","unstructured":"Penon-Portmann, M., Blair, D. R. & Harmatz, P. Current and new therapies for mucopolysaccharidoses. Pediatr. Neonatol. 64, S10\u2013S17. https:\/\/doi.org\/10.1016\/j.pedneo.2022.10.001 (2023).","journal-title":"Pediatr. Neonatol."},{"key":"88362_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","volume":"29","author":"T Okuyama","year":"2021","unstructured":"Okuyama, T. et al. A phase 2\/3 trial of pabinafusp alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II. Mol. Ther. 29, 671\u2013679. https:\/\/doi.org\/10.1016\/j.ymthe.2020.09.039 (2021).","journal-title":"Mol. Ther."},{"key":"88362_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva, C. et al. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. J. Control. Release 235, 34\u201347. https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.044 (2016).","journal-title":"J. Control. Release"},{"key":"88362_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s40259-024-00675-0","volume":"38","author":"A Zanetti","year":"2024","unstructured":"Zanetti, A. & Tomanin, R. Targeting neurological aspects of mucopolysaccharidosis type II: Enzyme replacement therapy and beyond. BioDrugs 38, 639\u2013655. https:\/\/doi.org\/10.1007\/s40259-024-00675-0 (2024).","journal-title":"BioDrugs"},{"key":"88362_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ymgme.2017.12.434","volume":"123","author":"K Sawamoto","year":"2018","unstructured":"Sawamoto, K., Chen, H. H., Almeciga-Diaz, C. J., Mason, R. W. & Tomatsu, S. Gene therapy for Mucopolysaccharidoses. Mol. Genet. Metab. 123, 59\u201368. https:\/\/doi.org\/10.1016\/j.ymgme.2017.12.434 (2018).","journal-title":"Mol. Genet. Metab."},{"key":"88362_CR21","doi-asserted-by":"publisher","first-page":"e8730","DOI":"10.15252\/emmm.201708730","volume":"10","author":"HF Gleitz","year":"2018","unstructured":"Gleitz, H. F. et al. Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms. EMBO Mol. Med. 10, e8730\u2013e8748. https:\/\/doi.org\/10.15252\/emmm.201708730 (2018).","journal-title":"EMBO Mol. Med."},{"key":"88362_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/ijms21010232","volume":"21","author":"JC Losada Diaz","year":"2019","unstructured":"Losada Diaz, J. C., Cepeda Del Castillo, J., Rodriguez-Lopez, E. A. & Almeciga-Diaz, C. J. Advances in the development of pharmacological chaperones for the Mucopolysaccharidoses. Int. J. Mol. Sci. 21, 232\u2013250. https:\/\/doi.org\/10.3390\/ijms21010232 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"88362_CR23","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/ajmg.a.32861","volume":"149A","author":"C Di Domenico","year":"2009","unstructured":"Di Domenico, C. et al. Intracranial gene delivery of LV-NAGLU vector corrects neuropathology in murine MPS IIIB. Am. J. Med. Genet. A 149A, 1209\u20131218. https:\/\/doi.org\/10.1002\/ajmg.a.32861 (2009).","journal-title":"Am. J. Med. Genet. A"},{"key":"88362_CR24","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.5414\/cpp47118","volume":"47","author":"KM Hemsley","year":"2009","unstructured":"Hemsley, K. M. & Hopwood, J. J. Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases. Int. J. Clin. Pharmacol. Ther. 47, S118\u2013S123. https:\/\/doi.org\/10.5414\/cpp47118 (2009).","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"88362_CR25","doi-asserted-by":"publisher","first-page":"17R","DOI":"10.1093\/glycob\/cwg047","volume":"13","author":"AD Elbein","year":"2003","unstructured":"Elbein, A. D., Pan, Y. T., Pastuszak, I. & Carroll, D. New insights on trehalose: A multifunctional molecule. Glycobiology 13, 17R-27R. https:\/\/doi.org\/10.1093\/glycob\/cwg047 (2003).","journal-title":"Glycobiology"},{"key":"88362_CR26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2174\/1389203724666230606154719","volume":"24","author":"E Sharma","year":"2023","unstructured":"Sharma, E. et al. Trehalose and its diverse biological potential. Curr. Protein Pept. Sci. 24, 503\u2013517. https:\/\/doi.org\/10.2174\/1389203724666230606154719 (2023).","journal-title":"Curr. Protein Pept. Sci."},{"key":"88362_CR27","doi-asserted-by":"publisher","first-page":"24261","DOI":"10.1074\/jbc.M101487200","volume":"276","author":"N Benaroudj","year":"2001","unstructured":"Benaroudj, N., Lee, D. H. & Goldberg, A. L. Trehalose accumulation during cellular stress protects cells and cellular proteins from damage by oxygen radicals. J. Biol. Chem. 276, 24261\u201324267. https:\/\/doi.org\/10.1074\/jbc.M101487200 (2001).","journal-title":"J. Biol. Chem."},{"key":"88362_CR28","doi-asserted-by":"publisher","first-page":"e3099","DOI":"10.1038\/cddis.2017.475","volume":"8","author":"XY Wang","year":"2017","unstructured":"Wang, X. Y. et al. Trehalose protects against cadmium-induced cytotoxicity in primary rat proximal tubular cells via inhibiting apoptosis and restoring autophagic flux. Cell Death Dis. 8, e3099\u2013e3109. https:\/\/doi.org\/10.1038\/cddis.2017.475 (2017).","journal-title":"Cell Death Dis."},{"key":"88362_CR29","doi-asserted-by":"publisher","first-page":"8402","DOI":"10.1096\/fj.201902528RRR","volume":"34","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Trehalose reduces bone loss in experimental biliary cirrhosis rats via ERK phosphorylation regulation by enhancing autophagosome formation. FASEB J. 34, 8402\u20138415. https:\/\/doi.org\/10.1096\/fj.201902528RRR (2020).","journal-title":"FASEB J."},{"key":"88362_CR30","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1007\/s12035-020-01942-1","volume":"57","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Wang, J., Hsiung, G. R. & Song, W. Trehalose inhibits abeta generation and plaque formation in Alzheimer\u2019s disease. Mol. Neurobiol. 57, 3150\u20133157. https:\/\/doi.org\/10.1007\/s12035-020-01942-1 (2020).","journal-title":"Mol. Neurobiol."},{"key":"88362_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/diagnostics11020273","volume":"11","author":"B Celik","year":"2021","unstructured":"Celik, B., Tomatsu, S. C., Tomatsu, S. & Khan, S. A. Epidemiology of Mucopolysaccharidoses update. Diagnostics 11, 273\u2013309. https:\/\/doi.org\/10.3390\/diagnostics11020273 (2021).","journal-title":"Diagnostics"},{"key":"88362_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1651-2227.2002.tb03116.x","volume":"91","author":"R Froissart","year":"2002","unstructured":"Froissart, R., Moreira da Silva, I., Guffon, N., Bozon, D. & Maire, I. Mucopolysaccharidosis type II-genotype\/phenotype aspects. Acta Paediatr. Suppl. 91, 82\u201387. https:\/\/doi.org\/10.1111\/j.1651-2227.2002.tb03116.x (2002).","journal-title":"Acta Paediatr. Suppl."},{"key":"88362_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-015-0356-0","volume":"10","author":"SY Cho","year":"2015","unstructured":"Cho, S. Y. et al. Effect of systemic high dose enzyme replacement therapy on the improvement of CNS defects in a mouse model of mucopolysaccharidosis type II. Orphanet. J. Rare Dis. 10, 141\u2013152. https:\/\/doi.org\/10.1186\/s13023-015-0356-0 (2015).","journal-title":"Orphanet. J. Rare Dis."},{"key":"88362_CR34","doi-asserted-by":"publisher","first-page":"107709","DOI":"10.1016\/j.ymgme.2023.107709","volume":"140","author":"JH Seo","year":"2023","unstructured":"Seo, J. H., Kosuga, M., Hamazaki, T., Shintaku, H. & Okuyama, T. Intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II: Final report of 5-year results from a Japanese open-label phase 1\/2 study. Mol. Genet. Metab. 140, 107709\u2013107717. https:\/\/doi.org\/10.1016\/j.ymgme.2023.107709 (2023).","journal-title":"Mol. Genet. Metab."},{"key":"88362_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.omtm.2021.02.018","volume":"21","author":"JH Seo","year":"2021","unstructured":"Seo, J. H., Kosuga, M., Hamazaki, T., Shintaku, H. & Okuyama, T. Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II. Mol. Ther. Methods Clin. Dev. 21, 67\u201375. https:\/\/doi.org\/10.1016\/j.omtm.2021.02.018 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"88362_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ymthe.2018.12.005","volume":"27","author":"T Okuyama","year":"2019","unstructured":"Okuyama, T. et al. Iduronate-2-sulfatase with anti-human transferrin receptor antibody for neuropathic Mucopolysaccharidosis II: A phase 1\/2 trial. Mol. Ther. 27, 456\u2013464. https:\/\/doi.org\/10.1016\/j.ymthe.2018.12.005 (2019).","journal-title":"Mol. Ther."},{"key":"88362_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1517\/17425247.2014.952627","volume":"12","author":"WM Pardridge","year":"2015","unstructured":"Pardridge, W. M. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody. Expert Opin. Drug Deliv. 12, 207\u2013222. https:\/\/doi.org\/10.1517\/17425247.2014.952627 (2015).","journal-title":"Expert Opin. Drug Deliv."},{"key":"88362_CR38","doi-asserted-by":"publisher","first-page":"101201","DOI":"10.1016\/j.omtm.2024.101201","volume":"32","author":"MC Smith","year":"2024","unstructured":"Smith, M. C. et al. Comparative dose effectiveness of intravenous and intrathecal AAV9.CB7.hIDS, RGX-121, in Mucopolysaccharidosis type II mice. Mol. Ther. Methods Clin. Dev. 32, 101201\u2013101215. https:\/\/doi.org\/10.1016\/j.omtm.2024.101201 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"88362_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ecoenv.2019.06.007","volume":"181","author":"KC Qu","year":"2019","unstructured":"Qu, K. C., Wang, Z. Y., Tang, K. K., Zhu, Y. S. & Fan, R. F. Trehalose suppresses cadmium-activated Nrf2 signaling pathway to protect against spleen injury. Ecotoxicol. Environ. Saf. 181, 224\u2013230. https:\/\/doi.org\/10.1016\/j.ecoenv.2019.06.007 (2019).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"88362_CR40","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1007\/s12035-023-03824-8","volume":"61","author":"P Kumar","year":"2024","unstructured":"Kumar, P. et al. Trehalose promotes clearance of proteotoxic aggregation of neurodegenerative disease-associated aberrant proteins. Mol. Neurobiol. 61, 4055\u20134073. https:\/\/doi.org\/10.1007\/s12035-023-03824-8 (2024).","journal-title":"Mol. Neurobiol."},{"key":"88362_CR41","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.4103\/1673-5374.308085","volume":"16","author":"M Khalifeh","year":"2021","unstructured":"Khalifeh, M., Barreto, G. E. & Sahebkar, A. Therapeutic potential of trehalose in neurodegenerative diseases: The knowns and unknowns. Neural. Regen. Res. 16, 2026\u20132027. https:\/\/doi.org\/10.4103\/1673-5374.308085 (2021).","journal-title":"Neural. Regen. Res."},{"key":"88362_CR42","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nrcardio.2017.97","volume":"14","author":"K Huynh","year":"2017","unstructured":"Huynh, K. Atherosclerosis: Trehalose induces macrophage autophagy-lysosomal biogenesis. Nat. Rev. Cardiol. 14, 444. https:\/\/doi.org\/10.1038\/nrcardio.2017.97 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"88362_CR43","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s12035-015-9173-7","volume":"53","author":"Q He","year":"2016","unstructured":"He, Q. et al. Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV alpha-synuclein rat model of Parkinson\u2019s disease. Mol. Neurobiol. 53, 2258\u20132268. https:\/\/doi.org\/10.1007\/s12035-015-9173-7 (2016).","journal-title":"Mol. Neurobiol."},{"key":"88362_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm985","volume":"10","author":"M Tanaka","year":"2004","unstructured":"Tanaka, M. et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med. 10, 148\u2013154. https:\/\/doi.org\/10.1038\/nm985 (2004).","journal-title":"Nat. Med."},{"key":"88362_CR45","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2174\/1389450115666140225104705","volume":"15","author":"E Emanuele","year":"2014","unstructured":"Emanuele, E. Can trehalose prevent neurodegeneration? Insights from experimental studies. Curr. Drug Targets 15, 551\u2013557. https:\/\/doi.org\/10.2174\/1389450115666140225104705 (2014).","journal-title":"Curr. Drug Targets"},{"key":"88362_CR46","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/15548627.2018.1535292","volume":"15","author":"P Rusmini","year":"2019","unstructured":"Rusmini, P. et al. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy 15, 631\u2013651. https:\/\/doi.org\/10.1080\/15548627.2018.1535292 (2019).","journal-title":"Autophagy"},{"key":"88362_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/jcm11010247","volume":"11","author":"M Mobini","year":"2022","unstructured":"Mobini, M. et al. Impact of intravenous trehalose administration in patients with Niemann-pick disease types A and B. J. Clin. Med. 11, 247\u2013257. https:\/\/doi.org\/10.3390\/jcm11010247 (2022).","journal-title":"J. Clin. Med."},{"key":"88362_CR48","unstructured":"Parenti, G., Menzies, S. A. & Zhang, D. Compositions and methods for the treatment of lysosomal storage disorders and disorders characterized by lysosomal dysfunction. WO2017185010A1 (2017)."},{"key":"88362_CR49","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.2174\/0929867330666230406102555","volume":"31","author":"M Mobini","year":"2024","unstructured":"Mobini, M. et al. Effects of trehalose administration in patients with Mucopolysaccharidosis type III. Curr. Med. Chem. 31, 3033\u20133042. https:\/\/doi.org\/10.2174\/0929867330666230406102555 (2024).","journal-title":"Curr. Med. Chem."},{"key":"88362_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.parkreldis.2019.12.007","volume":"70","author":"MA Noorasyikin","year":"2020","unstructured":"Noorasyikin, M. A. et al. Oral trehalose maybe helpful for patients with spinocerebellar ataxia 3 and should be better evaluated. Parkinsonism Relat. Disord. 70, 42\u201344. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.12.007 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"88362_CR51","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s10545-007-0641-8","volume":"30","author":"AR Garcia","year":"2007","unstructured":"Garcia, A. R., Pan, J., Lamsa, J. C. & Muenzer, J. The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome). J. Inherit. Metab. Dis. 30, 924\u2013934. https:\/\/doi.org\/10.1007\/s10545-007-0641-8 (2007).","journal-title":"J. Inherit. Metab. Dis."},{"key":"88362_CR52","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3390\/biomedicines12102224","volume":"12","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. Trehalose rescues postmenopausal osteoporosis induced by ovariectomy through alleviating osteoblast pyroptosis via promoting autophagy. Biomedicines 12, 2224\u20132242. https:\/\/doi.org\/10.3390\/biomedicines12102224 (2024).","journal-title":"Biomedicines"},{"key":"88362_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.21037\/atm.2019.05.73","volume":"7","author":"X Xu","year":"2019","unstructured":"Xu, X. et al. Trehalose enhances bone fracture healing in a rat sleep deprivation model. Ann. Transl. Med. 7, 297\u2013307. https:\/\/doi.org\/10.21037\/atm.2019.05.73 (2019).","journal-title":"Ann. Transl. Med."},{"key":"88362_CR54","doi-asserted-by":"publisher","first-page":"e54645","DOI":"10.1371\/journal.pone.0054645","volume":"8","author":"J Zhao","year":"2013","unstructured":"Zhao, J. et al. Trehalose maintains bioactivity and promotes sustained release of BMP-2 from lyophilized CDHA scaffolds for enhanced osteogenesis in vitro and in vivo. PLoS One 8, e54645\u2013e54660. https:\/\/doi.org\/10.1371\/journal.pone.0054645 (2013).","journal-title":"PLoS One"},{"key":"88362_CR55","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/s0271-5317(01)00315-3","volume":"21","author":"C Arai","year":"2001","unstructured":"Arai, C. et al. Trehalose suppresses lipopolysaccharide-induced osteoclastogenesis bone marrow in mice. Nutr. Res. 21, 993\u2013999. https:\/\/doi.org\/10.1016\/s0271-5317(01)00315-3 (2001).","journal-title":"Nutr. Res."},{"key":"88362_CR56","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00216-016-0076-x","volume":"409","author":"M Dufresne","year":"2017","unstructured":"Dufresne, M. et al. Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry. Anal. Bioanal. Chem. 409, 1425\u20131433. https:\/\/doi.org\/10.1007\/s00216-016-0076-x (2017).","journal-title":"Anal. Bioanal. Chem."},{"key":"88362_CR57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.mam.2006.08.005","volume":"27","author":"EL Eskelinen","year":"2006","unstructured":"Eskelinen, E. L. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Aspects. Med. 27, 495\u2013502. https:\/\/doi.org\/10.1016\/j.mam.2006.08.005 (2006).","journal-title":"Mol. Aspects. Med."},{"key":"88362_CR58","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/clinchem\/43.8.1325","volume":"43","author":"PJ Meikle","year":"1997","unstructured":"Meikle, P. J. et al. Diagnosis of lysosomal storage disorders: Evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker. Clin. Chem. 43, 1325\u20131335 (1997).","journal-title":"Clin. Chem."},{"key":"88362_CR59","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.ymthe.2021.01.027","volume":"29","author":"H Morimoto","year":"2021","unstructured":"Morimoto, H. et al. Clearance of heparan sulfate in the brain prevents neurodegeneration and neurocognitive impairment in MPS II mice. Mol. Ther. 29, 1853\u20131861. https:\/\/doi.org\/10.1016\/j.ymthe.2021.01.027 (2021).","journal-title":"Mol. Ther."},{"key":"88362_CR60","doi-asserted-by":"publisher","first-page":"e145445","DOI":"10.1172\/jci.insight.145445","volume":"6","author":"A Arguello","year":"2021","unstructured":"Arguello, A. et al. Iduronate-2-sulfatase transport vehicle rescues behavioral and skeletal phenotypes in a mouse model of Hunter syndrome. JCI Insight 6, e145445\u2013e145461. https:\/\/doi.org\/10.1172\/jci.insight.145445 (2021).","journal-title":"JCI Insight"},{"key":"88362_CR61","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ymgme.2012.05.005","volume":"107","author":"T Higuchi","year":"2012","unstructured":"Higuchi, T. et al. Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II. Mol. Genet. Metab. 107, 122\u2013128. https:\/\/doi.org\/10.1016\/j.ymgme.2012.05.005 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"88362_CR62","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.yexcr.2019.04.021","volume":"380","author":"J Kobolak","year":"2019","unstructured":"Kobolak, J. et al. Modelling the neuropathology of lysosomal storage disorders through disease-specific human induced pluripotent stem cells. Exp. Cell Res. 380, 216\u2013233. https:\/\/doi.org\/10.1016\/j.yexcr.2019.04.021 (2019).","journal-title":"Exp. Cell Res."},{"key":"88362_CR63","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ajhg.2009.07.011","volume":"85","author":"VA Polito","year":"2009","unstructured":"Polito, V. A. & Cosma, M. P. IDS crossing of the blood-brain barrier corrects CNS defects in MPSII mice. Am. J. Hum. Genet. 85, 296\u2013301. https:\/\/doi.org\/10.1016\/j.ajhg.2009.07.011 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"88362_CR64","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4062\/biomolther.2013.074","volume":"21","author":"SH Kwon","year":"2013","unstructured":"Kwon, S. H., Ma, S. X., Joo, H. J., Lee, S. Y. & Jang, C. G. Inhibitory effects of Eucommia ulmoides Oliv. bark on scopolamine-induced learning and memory deficits in mice. Biomol. Ther. 21, 462\u2013469. https:\/\/doi.org\/10.4062\/biomolther.2013.074 (2013).","journal-title":"Biomol. Ther."},{"key":"88362_CR65","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1271\/bbb.67.1284","volume":"67","author":"HJ Heo","year":"2003","unstructured":"Heo, H. J. et al. Effects of oleamide on choline acetyltransferase and cognitive activities. Biosci. Biotechnol. Biochem. 67, 1284\u20131291. https:\/\/doi.org\/10.1271\/bbb.67.1284 (2003).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"88362_CR66","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1248\/bpb.27.1041","volume":"27","author":"T Mamiya","year":"2004","unstructured":"Mamiya, T. et al. Effects of pre-germinated brown rice on beta-amyloid protein-induced learning and memory deficits in mice. Biol. Pharm. Bull. 27, 1041\u20131045. https:\/\/doi.org\/10.1248\/bpb.27.1041 (2004).","journal-title":"Biol. Pharm. Bull."},{"key":"88362_CR67","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/BF00212843","volume":"94","author":"M Sarter","year":"1988","unstructured":"Sarter, M., Bodewitz, G. & Stephens, D. N. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology 94, 491\u2013495. https:\/\/doi.org\/10.1007\/BF00212843 (1988).","journal-title":"Psychopharmacology"},{"key":"88362_CR68","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fnint.2013.00070","volume":"7","author":"AJ Montiel-Castro","year":"2013","unstructured":"Montiel-Castro, A. J., Gonzalez-Cervantes, R. M., Bravo-Ruiseco, G. & Pacheco-Lopez, G. The microbiota-gut-brain axis: Neurobehavioral correlates, health and sociality. Front. Integr. Neurosci. 7, 70\u201385. https:\/\/doi.org\/10.3389\/fnint.2013.00070 (2013).","journal-title":"Front. Integr. Neurosci."},{"key":"88362_CR69","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/metabo11070421","volume":"11","author":"I Benito-Cuesta","year":"2021","unstructured":"Benito-Cuesta, I., Ordonez-Gutierrez, L. & Wandosell, F. Trehalose reduces the secreted beta-amyloid levels in primary neurons independently of autophagy induction. Metabolites 11, 421\u2013436. https:\/\/doi.org\/10.3390\/metabo11070421 (2021).","journal-title":"Metabolites"},{"key":"88362_CR70","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41419-018-0749-9","volume":"9","author":"HJ Lee","year":"2018","unstructured":"Lee, H. J., Yoon, Y. S. & Lee, S. J. Mechanism of neuroprotection by trehalose: Controversy surrounding autophagy induction. Cell Death Dis. 9, 712\u2013723. https:\/\/doi.org\/10.1038\/s41419-018-0749-9 (2018).","journal-title":"Cell Death Dis."},{"key":"88362_CR71","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03115.x","volume":"91","author":"J Muenzer","year":"2002","unstructured":"Muenzer, J. et al. Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): A preliminary report. Acta. Paediatr. Suppl. 91, 98\u201399. https:\/\/doi.org\/10.1111\/j.1651-2227.2002.tb03115.x (2002).","journal-title":"Acta. Paediatr. Suppl."},{"key":"88362_CR72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2008.06.006","volume":"8","author":"XC Dong","year":"2008","unstructured":"Dong, X. C. et al. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab. 8, 65\u201376. https:\/\/doi.org\/10.1016\/j.cmet.2008.06.006 (2008).","journal-title":"Cell Metab."},{"key":"88362_CR73","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1038\/s41598-020-60530-4","volume":"10","author":"H Ueno","year":"2020","unstructured":"Ueno, H. et al. Effects of repetitive gentle handling of male C57BL\/6NCrl mice on comparative behavioural test results. Sci. Rep. 10, 3509\u20133521. https:\/\/doi.org\/10.1038\/s41598-020-60530-4 (2020).","journal-title":"Sci. Rep."},{"key":"88362_CR74","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ymgme.2018.04.011","volume":"125","author":"SA Khan","year":"2018","unstructured":"Khan, S. A. et al. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis. Mol. Genet. Metab. 125, 44\u201352. https:\/\/doi.org\/10.1016\/j.ymgme.2018.04.011 (2018).","journal-title":"Mol. Genet. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88362-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T07:24:22Z","timestamp":1739172262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88362-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88362"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88362-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4882"}}